Compare Aurobindo Pharma with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA SUN PHARMA AUROBINDO PHARMA/
SUN PHARMA
 
P/E (TTM) x 7.6 31.8 23.8% View Chart
P/BV x 1.9 4.2 44.3% View Chart
Dividend Yield % 0.6 0.9 62.4%  

Financials

 AUROBINDO PHARMA   SUN PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
SUN PHARMA
Mar-21
AUROBINDO PHARMA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,023654 156.5%   
Low Rs333339 98.4%   
Sales per share (Unadj.) Rs422.8139.6 302.8%  
Earnings per share (Unadj.) Rs92.09.5 965.9%  
Cash flow per share (Unadj.) Rs110.018.2 604.6%  
Dividends per share (Unadj.) Rs4.007.50 53.3%  
Avg Dividend yield %0.61.5 39.0%  
Book value per share (Unadj.) Rs374.3193.6 193.3%  
Shares outstanding (eoy) m585.942,399.34 24.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.63.6 45.1%   
Avg P/E ratio x7.452.1 14.2%  
P/CF ratio (eoy) x6.227.3 22.6%  
Price / Book Value ratio x1.82.6 70.7%  
Dividend payout %4.378.8 5.5%   
Avg Mkt Cap Rs m397,3981,190,430 33.4%   
No. of employees `000NANA-   
Total wages/salary Rs m35,35068,622 51.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m247,746334,981 74.0%  
Other income Rs m3,8098,592 44.3%   
Total revenues Rs m251,555343,573 73.2%   
Gross profit Rs m81,48041,616 195.8%  
Depreciation Rs m10,55420,800 50.7%   
Interest Rs m7451,414 52.7%   
Profit before tax Rs m73,99027,994 264.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,0985,147 390.5%   
Profit after tax Rs m53,89222,847 235.9%  
Gross profit margin %32.912.4 264.7%  
Effective tax rate %27.218.4 147.7%   
Net profit margin %21.86.8 318.9%  
BALANCE SHEET DATA
Current assets Rs m198,235304,421 65.1%   
Current liabilities Rs m106,652161,456 66.1%   
Net working cap to sales %37.042.7 86.6%  
Current ratio x1.91.9 98.6%  
Inventory Days Days19149 12.9%  
Debtors Days Days5299 52.3%  
Net fixed assets Rs m135,778336,682 40.3%   
Share capital Rs m5862,399 24.4%   
"Free" reserves Rs m218,713462,229 47.3%   
Net worth Rs m219,299464,628 47.2%   
Long term debt Rs m1,6848,981 18.8%   
Total assets Rs m334,013641,103 52.1%  
Interest coverage x100.320.8 482.5%   
Debt to equity ratio x00 39.7%  
Sales to assets ratio x0.70.5 142.0%   
Return on assets %16.43.8 432.3%  
Return on equity %24.64.9 499.8%  
Return on capital %33.86.2 544.6%  
Exports to sales %53.80-   
Imports to sales %16.40-   
Exports (fob) Rs m133,248NA-   
Imports (cif) Rs m40,615NA-   
Fx inflow Rs m133,24884,493 157.7%   
Fx outflow Rs m44,94630,334 148.2%   
Net fx Rs m88,30254,159 163.0%   
CASH FLOW
From Operations Rs m33,28961,704 54.0%  
From Investments Rs m5,9875,362 111.7%  
From Financial Activity Rs m-13,648-59,805 22.8%  
Net Cashflow Rs m25,8315,964 433.1%  

Share Holding

Indian Promoters % 48.8 54.7 89.2%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 37.2 32.8 113.5%  
FIIs % 21.7 12.7 170.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 45.3 106.3%  
Shareholders   329,940 653,359 50.5%  
Pledged promoter(s) holding % 24.4 6.4 384.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   AMI ORGANICS  ZIM LABORATORIES  RELISH PHARMA  BHARAT PARENTALS  VENUS REMEDIES  



Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Oct 22, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS